158 related articles for article (PubMed ID: 38456539)
1. RICH1 is a novel key suppressor of isoproterenol‑ or angiotensin II‑induced cardiomyocyte hypertrophy.
Wang S; Wang X; Ling L; Li C; Ren Z
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38456539
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
4. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.
Bi X; Zhang Y; Yu Y; Yuan J; Xu S; Liu F; Ye J; Liu P
Cell Biol Int; 2022 Feb; 46(2):288-299. PubMed ID: 34854520
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase.
Parreira RC; Gómez-Mendoza DP; de Jesus ICG; Lemos RP; Santos AK; Rezende CP; Figueiredo HCP; Pinto MCX; Kjeldsen F; Guatimosim S; Resende RR; Verano-Braga T
Proteomics Clin Appl; 2020 Jul; 14(4):e2000017. PubMed ID: 32506788
[TBL] [Abstract][Full Text] [Related]
7. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S
Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842
[TBL] [Abstract][Full Text] [Related]
8. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
[TBL] [Abstract][Full Text] [Related]
9. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
10. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
[TBL] [Abstract][Full Text] [Related]
11. Plantago asiatica L. seeds extract protects against cardiomyocyte injury in isoproterenol- induced cardiac hypertrophy by inhibiting excessive autophagy and apoptosis in mice.
Fan W; Zhang B; Wu C; Wu H; Wu J; Wu S; Zhang J; Yang X; Yang L; Hu Z; Wu X
Phytomedicine; 2021 Oct; 91():153681. PubMed ID: 34371252
[TBL] [Abstract][Full Text] [Related]
12. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730
[TBL] [Abstract][Full Text] [Related]
13. Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61.
Zhang Y; Wu H; Luo H; Luo Y; Huang C
Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36102309
[TBL] [Abstract][Full Text] [Related]
14. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
16. SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis.
Zhang X; Zheng C; Gao Z; Chen H; Li K; Wang L; Zheng Y; Li C; Zhang H; Gong M; Zhang H; Meng Y
Cardiovasc Drugs Ther; 2022 Jun; 36(3):437-447. PubMed ID: 34259984
[TBL] [Abstract][Full Text] [Related]
17. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
Dai YJ; Gong JX; Bian R
Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
[TBL] [Abstract][Full Text] [Related]
18. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
[TBL] [Abstract][Full Text] [Related]
19. Effect of SKF‑96365 on cardiomyocyte hypertrophy induced by angiotensin II.
Cheng H; Li J; Wu Q; Zheng X; Gao Y; Yang Q; Sun N; He M; Zhou Y
Mol Med Rep; 2020 Feb; 21(2):806-814. PubMed ID: 31974621
[TBL] [Abstract][Full Text] [Related]
20. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C
Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
